Leerink upgraded Galapagos (GLPG) to Outperform from Market Perform with a $40 price target
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GLPG:
- Galapagos NV to Wind Down Cell Therapy Business Following Strategic Review
- Galapagos intends to wind down cell therapy business
- Galapagos Appoints Fred Blakeslee as General Counsel
- Galapagos Updates on Cell Therapy Business Strategic Review
- Galapagos provides update on strategic alternatives for cell therapy business